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Summary
Purpose: The primary goal of the Genetics of Generalized Osteoarthritis (GOGO) study is to identify chromosomal regions associated with
increased susceptibility to generalized osteoarthritis (OA). Here we describe the study design and phenotype of the 2728 participants from
the 1145 families recruited for this study.
Methods: GOGO is an investigator-initiated collaboration involving seven clinical academic sites and sponsored by GlaxoSmithKline. Family
ascertainment was carried out between 1999 and 2002. A qualifying family required self-reported Caucasian ethnicity and at least two affected
siblings with clinical hand OA. We hypothesized that this clinical phenotype would facilitate identiﬁcation of participants with multijoint radio-
graphic OA (rOA) in and beyond the hand. The ‘‘gold standard’’ case deﬁnition, however, was based on rOA (KellgreneLawrence grade 2)
involving 3 hand joints distributed bilaterally and including at least one distal interphalangeal joint, with two of the three involved joints within
a joint group (distal interphalangeal, proximal interphalangeal, or carpometacarpal). Radiographs of hips, knees and spine were also obtained.
Additional siblings and living parents from qualifying families, both affected and unaffected, were invited to participate.
Results: A total of 2706 participants had complete clinical and radiological examination data. Of these, 2569 participants met clinical exam-
ination criteria for affected status; while 1963 (73%) participants met the prespeciﬁed radiographic criteria for affected status. This corre-
sponded to a total of 707 families with at least two affected siblings that met the hand rOA criteria. Of those individuals with rOA of the
hand, the frequency of rOA at other sites was highest for the knee (51%) and spine (54%), and less common for the hip (25%). Concordance
rates among hand affected siblings were greatest for spine (36%) followed by knee (31%) and hip (9%); a total of 53% of the affected sib pairs
were concordant for speciﬁc patterns of generalized rOA involving the hand and large joints (knees, hips or spine).
Conclusions: GOGO represents a large multicenter collection of families with multiple joint OA that have been characterized both clinically and
radiographically. The GOGO study will employ a comprehensive strategy for genetic screening based upon both qualitative and quantitative
radiographic trait analyses, circulating biomarkers in a quantitative trait-based analysis, ﬁne mapping, and candidate gene analysis. This sam-
ple should provide sufﬁcient power to detect linkage to OA associated genes.
ª 2006 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Osteoarthritis (OA) is the most common joint disease in
man, especially in aging populations, and is expected to
be the fourth leading cause of disability by the year
20201e3. Since 1941, a genetic component to OA has
been recognized4. Available evidence suggests that ge-
netic factors play a major role in OA, although the roles
of speciﬁc genes involved remain to be clariﬁed. The ge-
netic associations that have been elucidated most clearly
include two loci on chromosome 2q5,6 and one on chromo-
some 9q7. One of these is explained by polymorphisms
within the FRZB gene, which regulates skeletal develop-
ment and bone mass and is associated with a four-fold in-
creased unadjusted odds of hip OA in women5. A second
report of OA associations is related to polymorphisms in
the interleukin-1 gene cluster that either increase or re-
duce the odds of knee OA four- to ﬁve-fold in a United
Kingdom (UK) population, dependent upon the speciﬁc
gene polymorphism6. A third OA association, conferring
a 1.7- to 2.6-fold increased odds of knee or hip OA in Jap-
anese individuals, is related to polymorphisms in asporin7,
a small leucine-rich extracellular matrix protein8 that regu-
lates tumor growth factor b (TGFb)-mediated expression of
cartilage extracellular matrix genes. Potentially, many
other OA susceptibility loci remain to be discovered.
Heritability estimates for OA at the major joint sites of
hands, hips, knees and spine, range from 39 to 74%9.
The heritability estimate for the sum of affected joints at
each of these sites has been reported to be 78%10, sug-
gesting signiﬁcant genetic susceptibility for multijoint or
‘‘generalized’’ OA. The purpose of the Genetics of General-
ized Osteoarthritis (GOGO) study is to identify regions in the
human genome related to generalized OA affecting the
hands and other commonly affected joints (knees, hips
and spine).
No standardized deﬁnition of OA exists for the purposes
of genetic studies. This is reﬂected in the different ascer-
tainment strategies of previous studies (reviewed by
Jordan et al.11) that have included the following: hand
OA by physical examination or radiograph; hip and knee
OA by radiograph or history of joint replacement; and
spine OA by radiograph or magnetic resonance imaging
(MRI). Participants in the GOGO study were screened
on the basis of clinical hand OA but the gold standard di-
agnostic criteria were the presence of radiographic OA
(rOA).
We evaluated the utility of the clinical hand exam for de-
tecting radiographic disease in a subset of the total cohort
ascertained up until 2001, prior to the enrollment of all
families. We found that bony enlargement by clinical
hand exam identiﬁed radiographic hand OA [Kellgrene
Lawrence (KL) grade 2] with high sensitivity (79%), rea-
sonable speciﬁcity (52%), and a positive predictive value
(PPV) of 71%12. Bony enlargement of single distal inter-
phalangeal joints (DIPs) 2, 3 or 5, or the ﬁrst interphalan-
geal (IP) joint yielded the highest PPV for radiographic
disease. For the GOGO study, we therefore required bony
enlargement of at least one DIP as part of the screening
criteria. We further hypothesized that the GOGO hand
OA phenotype would facilitate identiﬁcation of participants
with multijoint rOA in and beyond the hand. This report
describes the GOGO study design and phenotypic charac-
teristics of the participating individuals and families. We
found that this screening strategy yielded a large cohort
with rOA of the hand, and a majority with rOA beyond
the hand.Methods
ASCERTAINMENT STRATEGY
GOGO is a collaborative study involving seven academic
sites, ﬁve in the United States (US) and two in the UK. Glax-
oSmithKline provided medical genetics expertise, coordina-
tion, and funding. Phenotype discussions and family
ascertainment were initiated at two sites in the US in
1999 (Duke University and the University of North Carolina
at Chapel Hill). The results of this pilot project were re-
viewed, and the ascertainment strategy ﬁnalized, in 2000.
Upon obtaining all the site-based Institutional Review Board
approvals, recruitment began at all sites in 2000 and was
completed in 2002. Written informed consent was obtained
for each participant in GOGO. Participants were recruited
primarily from Rheumatology clinics, hospital databases of
OA patients, pre-existing OA cohorts, and from the commu-
nity, by advertisements and word of mouth. A qualifying
family consisted of at least two siblings with self-reported
Caucasian ethnicity who fulﬁlled clinical GOGO hand OA
criteria (bony enlargement of 3 joints distributed bilater-
ally, including bony enlargement of at least one DIP joint,
and no more than three swollen metacarpophalangeal joints
as deﬁned below). In a family, the ﬁrst individual that met
clinical GOGO hand OA criteria was designated the pro-
band and was invited to participate along with at least one
clinically affected sibling. Once the sibling pair was posi-
tively identiﬁed as being clinically affected, the nuclear fam-
ily was invited to participate, together with potential affected
or unaffected siblings beyond the required two affecteds.
Living parents of the affected sibling pair were also invited
to participate. For the purposes of family based association
studies, unaffected status was assigned to any participant
who did not meet GOGO gold standard criteria for radio-
graphic hand OA. Near study initiation, we evaluated the
proportion of positive agreement (Ppos) and negative agree-
ment (Pneg)
13, and the PPV of the hand examination among
examiners. Thirty patients underwent clinical hand examina-
tions by each of the GOGO study personnel to assess bony
enlargement, ﬁrst carpometacarpal (CMC-1) squaring and
clinical impression regarding the presence or absence of
GOGO hand criteria. GOGO personnel were blinded to the
radiographic hand OA status of the patients. Results were
discussed and examinations were repeated in random order
the following day. The Ppos among examiners was 75%, and
Pneg was 58%. The PPV was described previously
12.
RADIOGRAPHIC PROCEDURES
Women of childbearing potential were required to un-
dergo a pregnancy test prior to radiography.
Hands: A posteroanterior (PA) radiograph of each hand
was performed with the beam centered on the third meta-
carpalphalangeal (MCP) joint.
Knees: A ﬁxed-ﬂexion PA knee radiograph was taken
with the SynaFlex X-ray positioning frame (Synarc, San
Francisco, CA)14. With this platform, the feet were exter-
nally rotated 10, the knees and thighs touched the vertical
platform anteriorly, and the X-ray beam was angulated 10
caudally. Skyline views of both patellae were taken with the
participant in the seated position, knees bent, and the beam
angled from the feet toward the knees.
Hips: An anteroposterior view of the pelvis was performed
with the participant supine and feet internally rotated 10.
Spine: A lateral view of the lumbar spine (L1eL5) was per-
formed with the participant recumbent, with left side down.
Lumbar spine radiographs were obtained at the US sites
122 V. B. Kraus et al.: GOGO study designonly (due to differences in research ethics approval systems
between the US and UK).
RADIOGRAPHIC GRADING
The phenotypic analyses reported herein were based on
KL criteria15 or grading of individual features using a photo-
graphic standard atlas16 that included joint space narrowing,
osteophytes, and other joint speciﬁc features such as cysts,
sclerosis, erosions, and chondrocalcinosis. In addition to
grading the DIPs, proximal interphalangeal (PIPs) and ﬁrst
CMCs, the MCP joints were also graded. KL grades, and os-
teophyte and joint space narrowing grades were assigned to
theMCPs using thePIP andDIP pictures in standard atlases’
templates15,16. Minimal interbone distances were measured
manually using a 7 comparator (Cone Instruments) with
a graduated reticule to the nearest 0.1 mm, for the hip and
the medial and lateral compartments of the knee. Lumbar
spine radiographs were scored for the presence and severity
of vertebral osteophyte according to a standard atlas16, and
disc narrowing (on a 0e3 scale based on the radiologists
expert opinion), and the presence or absence of end plate
sclerosis, vacuum disc phenomenon, facet joint OA, com-
pression fracture, platyspondyly and Scheuermann disease.
Radiographs were screened for evidence of abnormalities
due to rheumatoid arthritis (RA), gout, psoriasis, or hemo-
chromatosis. Individuals with chondrocalcinosis or erosive
OA were not excluded. A single experienced bone and joint
radiologist (JBR) interpreted all radiographs (approximately
19,096), representing 106,392 joints. Inter-rater reliability
(assessed with another trained radiologist) and intra-rater re-
liability were high for the radiologist’s reading of KL grades of
the knee and hip (weighted kappa 0.859 inter-rater and 0.886
intra-rater reliability) as described previously17.
Although many deﬁnitions of OA can, and are being eval-
uated in this study, for the purposes of these descriptive
analyses, the following criteria were used to deﬁne OA at
the various joint sites: knee rOA was deﬁned as KL grade
2 in at least one knee or a veriﬁed history of joint replace-
ment for OA; patellofemoral joint (PFJ) OA was deﬁned as
any osteophyte grade 2; hip rOA was deﬁned as KL grade
2, or minimal joint space width 2.5 mm, or the combina-
tion of joint space narrowing grade 2 and any osteophyte
of grade 1, or a veriﬁed history of joint replacement for OA;
lumbar spine OA was deﬁned as an osteophyte grade 1
(above or below the disc space) and disc narrowing 1 at
the same vertebral level.
GOGO GOLD STANDARD CRITERIA
The GOGO criteria for determining affection status were:
(1a) hand rOA of a minimum of three joints involving
DIPs, PIPs, or CMC-1 joints with two of the three
joints involved within the same joint group (for the
purpose of deﬁnition, the ﬁrst IP joint was consid-
ered to belong to the PIP group);
(1b) hand rOA of at least one DIP of digits 2e5;
(1c) hand rOA bilaterally distributed; and
(1d) no more than three swollen MCP joints by clinical
examination (as deﬁned in the Dictionary of the
Rheumatic Diseases18).
Participants were excluded on the basis of a clinical
diagnosis of systemic lupus erythematosus, a history or
radiographic evidence of RA, or psoriatic arthritis, or radio-
graphic and serological evidence of hemochromatosis. Ra-
diographs were screened for gout but this did not representan exclusionary criterion unless a gout ﬂare had occurred in
the previous 3 years or hand radiographs demonstrated
changes consistent with gout. Radiologic features that
were used to rule in RA in the hands included bilateral, sym-
metric disease, primarily involving the MCPs more severely
than the PIPs and DIPs. Radiocarpal and intercarpal in-
volvement were also regarded as suggestive of RA. Other
features included joint narrowing with little or no sclerosis,
periarticular osteopenia, marginal articular erosions, char-
acteristic malalignment at the wrist or MCP joints and
a lack of osteophytosis. In the knees, features of RA in-
cluded bilateral and symmetric involvement with diffuse nar-
rowing of all compartments but with a relative lack of
osteophytosis. Subchondral eburnation did not exclude
RA in the knees. In the hips, features included global nar-
rowing of the joint, again with little or no osteophytosis. Ero-
sions of the femoral neck were sought. As in the knee,
subchondral eburnation did not exclude RA. For gout in
the hands, features included focal soft tissue swelling, jux-
taarticular erosions, preservation of joint width and bone
density and an asymmetric distribution. No speciﬁc distribu-
tion of disease was expected for gout, therefore IP, MCP
and wrist joints were all inspected for gout. The evaluation
for psoriatic arthritis included assessment of erosions (at
the margins of joints or within joints), joint narrowing or wid-
ening (depending on the position of erosions), bilateral but
not necessarily symmetric distribution of joint abnormalities,
soft tissue swelling (either fusiform or focal), and ill-deﬁned
periosteal new bone production. Again as with gout, these
features were evaluated for all joint sites of the hands includ-
ing the wrists. The X-ray features that suggested hemochro-
matosis in the handwere exuberant osteophytes arising from
the volar and radial surfaces of the second and third meta-
carpal heads and prominent joint space narrowing of these
joints. Participants with this pattern on X-ray underwent mea-
surement of fasting transferrin saturation (iron/total iron bind-
ing capacity ratio) and if >55%, the individual and family
were excluded. No subjects met these serological criteria
for exclusion.
COLLECTION OF FAMILY AND RISK FACTOR DATA
The family history interview yielded a four-generation
pedigree documenting musculoskeletal history within 3 of
relationship of the proband. Data were entered into an elec-
tronic database using Cyrillic software (Oxfordshire, UK).
Data were also collected on general medical history, history
of musculoskeletal injury, joint surgery and joint replace-
ment, smoking history, physical activity, occupational his-
tory, estrogen use (women only), and OA symptoms using
the Western Ontario and McMaster Universities (WOMAC)
OA index19 (collected at six of the seven sites). Anthropo-
metric data collected included height, weight, and arm
span. We also collected data on the age of onset at which
joint symptoms began at each joint site. As reported previ-
ously20, hypermobility was assessed using the Beighton
score21. Trabecular and cortical bone density data were ac-
quired. Trabecular bone mineral density (BMD) was mea-
sured at the calcaneus using a Norland Apollo DEXA at
six of the investigative sites. To obtain estimates of cortical
bone density, the endosteal and periosteal radii of the
second metacarpal of the dominant hand were measured
according to the method of Spencer22. Pinch and grip
strength and the AUStralian CANadian Osteoarthritis
Hand Index (AUSCAN)23e25 were measured at two investi-
gative sites26, and hand thermography was performed at
one investigative site27.
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On the day of participant assessment, 28 ml of whole
blood (5 ml for sera and 23 ml for plasma and future DNA
extraction), and 2 ml of unspun urine were collected. Sam-
ples were stored at 80C until shipment to a central repos-
itory at GlaxoSmithKline. For all participants, blood spots
were collected on ﬁlter cards (Schleicher & Schuell, Keene,
NH) as an additional source of DNA and for later veriﬁcation
of genotyping or sample identity if needed28.
SAMPLE SIZE AND POWER CONSIDERATIONS
A sample size of a minimum of 700 sib pairs, encompass-
ing half the families, was chosen to provide adequate power
to detect genes of moderate to large effect in the initial ge-
nome screen for linkage. Allowing for heterogeneity, it was
estimated that there was 80% power to detect genes with
a sibling recurrence risk ratio (RRR) of at least 1.5 in a homo-
geneous sample comprising 50% of the families, or a sibling
RRR of at least 2.0 in a homogeneous sample composed of
20% of the families. These RRRs represent either genes of
small effect or genes of moderate to large effect operating
in a smaller subset of families. Thus theGOGOstudywas de-
signed to provide adequate power to detect genes of small to
moderate effect, especially in the total sample.
STATISTICAL ANALYSIS
Descriptive statistics per person and family were per-
formed; we present no P-values due to the correlated na-
ture of the data. BMI was separated into four categories
ranging from normal to severely obese29. Categories of af-
fected status were deﬁned by the radiological criteria. Con-
cordance was deﬁned as two siblings with matching
involvement for a particular pattern of OA. Discordance for
hand OA was deﬁned as lacking GOGO hand rOA criteria
while having clinical OA by examination. Self-reported age
of onset was evaluated for occurrence of OA at each joint
site. Some participants had stated ages of OA onset that
were below age 30 (between 1.3% and 2.4% depending
on the speciﬁc joint with the exception of spine which was
10.7%). Any self-reported ages of onset within the ﬁrst de-
cade of life were deemed highly improbable to be OA in
our samples derived from the US and UK. Therefore, itwas assumed that all such values below 10 were intended
to represent the number of years prior to the initial study
visit rather than an age of onset. This subset represented
between 0.25% and 0.64% of all participants; the effect of
this imputation was to increase the age of onset 0.4 years.
Results
PATTERNS OF HAND OA
A total of 2728 participants from 1145 families were en-
rolled (65% through the ﬁve US sites and 35% through
the two UK sites) (Table I). The median family size was
two with a maximum of nine siblings ascertained in any
one family. In addition, one or two parents (6%) of the 66
families participated. A total of 2706 participants had com-
plete clinical and radiological examination criteria. Of these,
2569 participants (95% of cohort) were affected by clinical
hand OA criteria and 1963 (73%) met the hand rOA criteria.
Clinical and radiographic determinations of affected status
were discordant in 750 participants (Table II). Rarely was
a participant affected radiographically without meeting clin-
ical criteria of affection status (3% of all participants). More
commonly, discordant individuals met clinical hand OA cri-
teria but did not meet the hand rOA criteria (25% of all par-
ticipants). Overall the sensitivity of the clinical criteria was
96% (range among the seven sites 93e97%), speciﬁcity
was 9% (4e34%) and positive predictive value was 74%
(59e90%). Unaffecteds for the hand rOA criteria were youn-
ger (mean of 59 years vs 69 years), more likely to be male
(27% vs 20%), but qualitatively similar with respect to BMI
(mean 29 kg/m2) (Table III).
A total of 707 families had at least two siblings that met the
hand rOA criteria. The number of sibling pairs (based on
Forthofer30: [n(n 1)/2] sib pairs for n siblings) equaled
1936 with 1130 effective sibling pairs in which both siblings
had rOA of the hand. The majority (80.4%) of the overall sam-
ples was females, overall mean agewas 66 years, with 34.5%
obese (BMI 30.0 kg/m2), and 72.3% either overweight,
obese, or severely obese (BMI 25.0 kg/m2) (Table IV).
The most frequent hand rOA phenotypes in the affected
participants are shown in Table V: these were DIP/PIP/
CMC-1 (34.6%), followed by DIP/PIP/MCP/CMC-1
(28.9%) and DIP/PIP (28.6%). The various hand OA pheno-
types involved, on average, 12 affected hand joints perTable I
Sites participating in the GOGO study network and number of families identified
Principal investigators Institution Location No. of
families
No. of
individuals
No of hand
rOA affected
individuals
No of hand
rOA affected
sib pairs
Virginia B Kraus Duke University Durham, NC 209 535 412 275
Joanne M Jordan University of
North Carolina
Chapel Hill,
NC
201 527 390 242
Michael Doherty University of
Nottingham
Nottingham, UK 203 494 412 270
Anthony G Wilson University of
Shefﬁeld
Shefﬁeld, UK 209 462 291 153
Marc C Hochberg University of
Maryland
Baltimore, MD 124 291 191 83
Roland Moskowitz
and Michele
Hooper
Case Western
Reserve University
Cleveland, OH 134 279 184 79
Richard Loeser Rush Medical
College
Chicago, IL 65 140 83 28
1145 2728 1963 1130
124 V. B. Kraus et al.: GOGO study designindividual and therefore, many more than the minimum
three joint hand rOA involvement required by the GOGO cri-
teria. The distribution of the number of affected joints for
each pattern of hand rOA is shown in Fig. 1. The overall fre-
quency of MCP rOA was 36.2%. First CMC disease almost
always occurred in combination with DIP/PIP involvement
and rarely with DIP disease alone (0.5%) or DIP/MCP dis-
ease (0.2%). The self-reported mean ages of onset of these
various hand rOA phenotypes were not qualitatively differ-
ent by joint groups involved (Table V).
Frequencies of large joint involvement
The majority of individuals who met hand rOA criteria also
had large joint involvement. The frequencies of large joint
rOA in individuals who met rOA hand criteria (n¼ 1963)
were highest for the knee (51%, with 8% on the basis of ti-
biofemoral joint replacement), and intervertebral disc dis-
ease of the spine (54%), and lowest for the hip (25%, with
6% on the basis of hip joint replacement). A total of 61%
of participants had knee or hip OA, while 16% had both
Table II
Comparison of affected status by criteria used: radiographic vs clin-
ical for all GOGO participants with complete radiographic informa-
tion (N¼ 2706)
Affected by clinical
GOGO criteria
Affected by GOGO radiographic
hand criteria
Yes No Totals
Yes 1891 (70%) 678 (25%) 2569 (95%)
No 72 (3%) 65 (2%) 137 (5%)
Total 1963 (73%) 743 (27%) 2706* (100%)
Radiographic affected was deﬁned as a minimum of three joints
with KL 2 OA, distributed bilaterally, involving DIP, PIP, or ﬁrst
CMC joints with two of the three joints involved within the same joint
group (ﬁrst IP joint considered a PIP); and involvement of at least
one DIP of digits 2e5. Clinically affected was deﬁned as bony en-
largement of a minimum of three joints, distributed bilaterally, in-
volving DIP, PIP, or ﬁrst CMC joints with two of the three joints
involved within the same joint group (ﬁrst IP joint considered
a PIP group); and involvement of at least one DIP of digits 2e5;
and fewer than three swollen MCP joints.
*Complete clinical and radiographic data were unavailable for 22
of the 2728 participants, therefore this table is based upon the
N¼ 2706 for whom complete data were available.
Table III
Demographics of the affected based on radiographic criteria for
hand vs unaffecteds in the GOGO study population
Affected
(N¼ 1963)
Unaffected
(N¼ 743)
Age e mean years (SD) 69 (9) 59 (9)
Range (years) 39e105 25e86
Gender e male 20% 27%
Body mass index (kg/m2)
Mean (SD) 29 (6) 29 (7)
% Overweight (25.0e29.9) 38 33
% Obese (30e34.9) 21 24
% Morbidly obese (35) 13 18
% Overweight or obese 72 75
Radiographic criteria for affected status are given in Table II.hip and knee OA. Although one site in the UK recruited
some GOGO participants from a preexisting knee OA co-
hort, the overall frequencies of the combined phenotypes
were similar in the US and UK (Fig. 2). The availability of
lumbar spine radiographs in the US participants revealed
that half of the ‘‘hand only’’ affecteds, and a full two-thirds
of the ‘‘hand/knee’’ affecteds, had more complex pheno-
types that included spine OA. The self-reported mean
ages of onset (SD) for hip and knee were qualitatively
slightly greater than those of the hand while spine was sim-
ilar to hand: left hip e 59.4 (10.6); right hip e 59.5 (10.5); left
knee e 58.1 (11.2); right knee e 58.2 (11.2); and the lower
back in the US subjects e 54.7 (12.2) years.
A total of 319 participants (16%) had radiographic PFJ
rOA and all but 39 of these participants also had rOA of
the tibiofemoral joint. Thus, PFJ rOA occurred in the setting
of tibiofemoral rOA in an overwhelming majority (88%) and
rarely in isolation. A majority (87%) of affected sib pairs
were concordant for speciﬁc patterns of multijoint rOA:
60% were concordant for hand only, 31% for knee, 9% for
hip, and 36% for knee or hip, and in the US, the ﬁgure for
knee, hip or spine was 53%.
Discussion
The GOGO study is the largest family based linkage
study of OA in the world. A major strength of the study is
Table V
Frequencies of affected individuals and age of onset by joint group
presentation
Joint group Affected (%)
(N¼ 1963)
Median,
no. of hand
joints involved
Age of
onset
(years, SD)
DIP only 1 (0.1%) 3 48.0
DIP, MCP, CMC-1 only 4 (0.2%) 4 55.3 (7.1)
DIP, CMC-1 only 9 (0.5%) 3 55.6 (11.3)
DIP, PIP, MCP only 139 (7.1%) 11 56.3 (11.7)
DIP, PIP only 562 (28.6%) 7 54.1 (10.3)
DIP, PIP, MCP, CMC-1 568 (28.9%) 17 56.3 (11.8)
DIP, PIP, CMC-1 only 680 (34.6%) 10 54.8 (11.6)
Table IV
Demographics of the subset of participants that met the radio-
graphic criteria for hand affected status in the GOGO study
population
Females
(N¼ 1578,
80.4%)
Males
(N¼ 385,
19.6%)
All hand rOA
participants
(N¼ 1963)
Age e mean
years (SD)
69 (9) 69 (8) 69 (9)
Range (years) 44e95 39e105 39e105
Body mass
index (kg/m2)
Mean (SD) 29 (6) 29 (5) 29 (6)
% Overweight
(25.0e29.9)
35 48 38
% Obese
(30e34.9)
21 24 21
% Morbidly
obese (35)
14 9 13
% Overweight
or obese
70 81 72
Radiographic criteria for affected status are given in Table II.
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Fig. 1. The number of individuals with speciﬁed patterns of hand rOA. The patterns of hand rOA are shown for the 1963 participants meeting
GOGO gold standard hand rOA criteria. (A) Number of joints involved for the patterns DIP/PIP, DIP/PIP/MCP, and DIP/MCP/CMC-1; (B) num-
bers of joints involved for the patterns DIP/PIP/CMC-1, DIP/PIP/MCP/CMC-1, and DIP/CMC-1. One participant had only DIP involvement with
three total affected joints (not shown).the availability of extensive radiographic phenotyping of
subjects. In addition, the study has produced a repository
of biospecimens for future proteomics and biomarker work
to complement the genetic analysis. We used the presence
of nodal OA characterized by bony enlargement of hand
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Fig. 2. Frequency of multiple joint involvement with OA. The fre-
quencies of rOA at various sites, and sites in combination, are
shown for the US in light gray, and for the UK in dark gray for the
1963 participants meeting GOGO gold standard hand rOA criteria.
The groups represented are mutually exclusive. The frequencies of
one joint site (hand only), two sites (hand/knee and hand/hip) or
three sites (hand/knee/hip) are shown. The frequency of spine
OA in combination with the aforementioned phenotypes is indicated
by the stippled bars. Because the US sites were the only ones to
perform lumbar spine radiography, these stippled bars, represent-
ing spine OA frequencies, are only found above the bars represent-
ing US frequencies.joints as the screening procedure to determine eligibility
for entry into the study. Bony enlargement of the hand joints
is strongly familial and has long been considered a marker
of OA4. This clinical screening strategy yielded 62% of fam-
ilies with at least one affected sib pair with hand rOA.
We reviewed selected literature that presented popula-
tion-based estimates of OA prevalence. A study from Zoe-
termeer in the Netherlands was especially informative
because it provided prevalence rates for radiographically
deﬁned OA of the hand, knee, hip and spine31. For hand,
using the DIP as the marker, 10% of males and 7% of fe-
males in the Dutch study had radiographically conﬁrmed
OA before age 45. In GOGO, 16% of the population had
early onset hand rOA prior to age 45. In addition, ﬁrst
CMC disease almost always occurred in combination with
DIP/PIP involvement as noted previously by Hirsch
et al.32. With regard to the patterns of rOA in this cohort,
MCP rOA was common (36%) despite a lack of evidence
for hemochromatosis on the basis of serological screening.
This prevalence is quite comparable to the reported preva-
lence of MCP OA in the Caucasian Framingham cohort that
ranged from 29% (women) to 33% (men)33.
Although few studies account for spine OA, it was very
common in our cohort, occurring in more than half of all
hand rOA affected individuals. A similar high frequency ag-
gregation of hand and spine OA, up to 59%, has been re-
ported for a Dutch cohort of 191 sibling pairs in which hand,
spine, knee and hip radiographs were all obtained34. Overall,
the GOGO screening strategy yielded a large number of indi-
viduals with rOA joint involvement in and beyond the hand.
A total of 25%of participants (678)met clinical handOAcri-
teria but did not have sufﬁcient radiographic evidence tomeet
the hand rOA criteria. Due to the lack of standardized hand
OA deﬁnitions, we relied on the expert opinion of the
GOGOprincipal investigators to derive the relatively stringent
hand rOA criteria. The wealth of phenotypic radiographic in-
formation provided on these participants will nevertheless
be informative for quantitative trait analyses that account for
total numbers of joints involved and the severity of joint in-
volvement.Other genetic studies ofOAhave successfully uti-
lized sumscores of affected joints for quantifying anddeﬁning
OA35.Quantitative trait analysis is a powerful strategy capital-
izing on all the phenotypic information provided by each
126 V. B. Kraus et al.: GOGO study designparticipant, and does not require a priori deﬁnitions of OA.
This strategy will be utilized in the future as part of a compre-
hensive analysis of the GOGO data.
It is clear that OA is etiologically heterogeneous. The ex-
tensive radiographic phenotyping in the GOGO study
yielded families with distinct patterns of OA involvement
with high concordance rates. We do not expect the same
gene (or combination of genes) to be operating in every
family. Because multiple family members were ascertained
when available, this screening strategy yielded a total of
1130 sibling pairs with rOA of the hand, providing great
power to detect linkage to genes associated with various
patterns of OA. This approach incorporates a detailed study
of genetic factors and geneeenvironment interactions that
may eventually assist in identifying targeted preventive
strategies, promote a better understanding of basic disease
mechanisms, and facilitate development of more effective
treatments for OA.
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